EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing
- PMID: 10982800
- DOI: 10.1074/jbc.M005739200
EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing
Abstract
Ewing's sarcoma displays a characteristic chromosomal translocation that results in fusion of the N-terminal domain of the Ewing's sarcoma protein (EWS) to the C-terminal DNA-binding domain of the ETS family transcription factor Fli-1 (Friend leukemia integration-1). EWS possesses structural motifs suggesting a role in transactivation as well as RNA binding. We demonstrate that wild-type EWS protein functions as an adapter molecule coupling transcription to RNA splicing by binding to hyperphosphorylated RNA polymerase II through the N-terminal domain of EWS and recruiting serine-arginine (SR) splicing factors through the C-terminal domain of EWS. The oncogenic EWS.Fli-1 fusion protein retains the ability to bind to hyperphosphorylated RNA polymerase II but lacks the ability to recruit SR proteins because of replacement of the C-terminal domain of EWS by Fli-1. In an in vivo splicing assay, the EWS.Fli-1 fusion protein inhibits SR protein-mediated E1A pre-mRNA splicing in a dominant-negative manner. These results indicate that EWS.Fli-1 interferes with the normal function of EWS and implicate uncoupling of gene transcription from RNA splicing in the pathogenesis of Ewing's sarcoma.
Similar articles
-
Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.Cancer Res. 2001 May 1;61(9):3586-90. Cancer Res. 2001. PMID: 11325824
-
The splicing factor U1C represses EWS/FLI-mediated transactivation.J Biol Chem. 2000 Aug 11;275(32):24865-71. doi: 10.1074/jbc.M001661200. J Biol Chem. 2000. PMID: 10827180
-
EWS/FLI alters 5'-splice site selection.J Biol Chem. 2001 Jun 22;276(25):22317-22. doi: 10.1074/jbc.M008950200. Epub 2001 Apr 11. J Biol Chem. 2001. PMID: 11301318
-
Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma.Cell Cycle. 2006 Sep;5(18):2049-53. doi: 10.4161/cc.5.18.3213. Epub 2006 Sep 15. Cell Cycle. 2006. PMID: 16969112 Review.
-
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting.Oncotarget. 2016 Apr 5;7(14):17616-30. doi: 10.18632/oncotarget.7124. Oncotarget. 2016. PMID: 26848860 Free PMC article. Review.
Cited by
-
EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice.Mol Cell Biol. 2007 Nov;27(22):7918-34. doi: 10.1128/MCB.00099-07. Epub 2007 Sep 17. Mol Cell Biol. 2007. PMID: 17875932 Free PMC article.
-
Comprehensive profiling of mRNA splicing indicates that GC content signals altered cassette exon inclusion in Ewing sarcoma.NAR Cancer. 2022 Jan 14;4(1):zcab052. doi: 10.1093/narcan/zcab052. eCollection 2022 Mar. NAR Cancer. 2022. PMID: 35047826 Free PMC article.
-
One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma.J Bone Oncol. 2021 Dec 1;31:100404. doi: 10.1016/j.jbo.2021.100404. eCollection 2021 Dec. J Bone Oncol. 2021. PMID: 34976713 Free PMC article.
-
Chromosomal localization of Ewing sarcoma EWSR1/FLI1 protein promotes the induction of aneuploidy.J Biol Chem. 2021 Jan-Jun;296:100164. doi: 10.1074/jbc.RA120.014328. Epub 2020 Dec 10. J Biol Chem. 2021. PMID: 33293370 Free PMC article.
-
Mouse EWSR1 is crucial for spermatid post-meiotic transcription and spermiogenesis.Development. 2021 Jun 1;148(11):dev199414. doi: 10.1242/dev.199414. Epub 2021 Jun 8. Development. 2021. PMID: 34100066 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials